Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety

被引：0
|
作者：
Paola Ponzani
Cesare Berra
Alessandra Di Lelio
Paola Del Sindaco
Chiara Di Loreto
Francesco Reggiani
Giuseppe Lucisano
Maria Chiara Rossi
机构：
[1] SSD Endocrinologia,
[2] Diabetologia e Malattie Metaboliche ASL3 Genovese,undefined
[3] Humanitas Research Institute,undefined
[4] CORESEARCH,undefined
[5] Center for Outcomes Research and Clinical Epidemiology,undefined
[6] Servizio di Diabetologia del Perugino USL Umbria 1,undefined
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Add-on; Effectiveness; Glycemic variability; Hypoglycemia; Insulin degludec; Real-world data; Switch; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2209 / 2218
页数：9
相关论文
共 50 条
  • [1] Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
    Ponzani, Paola
    Berra, Cesare
    Di Lelio, Alessandra
    Del Sindaco, Paola
    Di Loreto, Chiara
    Reggiani, Francesco
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    DIABETES THERAPY, 2018, 9 (06) : 2209 - 2218
  • [2] Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety
    Ponzani, Paola
    Berra, Cesare
    Di Lelio, Alessandra
    Del Sindaco, Paola
    Di Loreto, Chiara
    Reggiani, Francesco
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    DIABETES THERAPY, 2020, 11 (01) : 97 - 105
  • [3] Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety
    Paola Ponzani
    Cesare Berra
    Alessandra Di Lelio
    Paola Del Sindaco
    Chiara Di Loreto
    Francesco Reggiani
    Giuseppe Lucisano
    Maria Chiara Rossi
    Diabetes Therapy, 2020, 11 : 97 - 105
  • [4] Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes in a Swedish setting
    Jendle, J. H.
    Thunander, M.
    Sjoberg, S.
    Ekman, B.
    Mardby, A. -C.
    Fernandes, J. Da Rocha
    Gundgaard, J.
    Ericsson, A.
    DIABETOLOGIA, 2019, 62 : S436 - S436
  • [5] The effect of insulin degludec in people with type 2 diabetes in real-world clinical practice in China
    Zhu, D.
    Chang, X.
    Lehrskov, L. L.
    Li, L.
    Nordentoft, M.
    Quan, J.
    Sha, Y.
    Xing, Z.
    Yang, C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [6] Switching from Premixed Insulin to Insulin Degludec/Insulin Aspart for the Management of Type 2 Diabetes Mellitus: Implications of a Real-World Study on Insulin Degludec Dosing
    Yiming Wu
    Junqing Zhang
    Ang Li
    Diabetes Therapy, 2024, 15 (12) : 2515 - 2523
  • [7] Real-World Assessment of Clinical Effectiveness when Switching to Insulin Degludec from Another Basal Insulin among Type 2 Diabetes Patients in the US
    Tibaldi, Joseph M.
    Hansen, Brian B.
    Wolden, Michael L.
    Moralea, Maria E.
    Yue, Yinan
    Weatherall, James
    Rodbard, Helena W.
    DIABETES, 2017, 66 : A261 - A261
  • [8] Real-world efficacy and safety of insulin degludec with mealtime rapid-acting insulin in type 1 diabetes in Indian pediatric population
    Kochar, Inderpal Singh
    Sethi, Aashish
    INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2018,
  • [9] Effectiveness of Insulin Degludec in Thai Patients with Diabetes Mellitus: Real-World Evidence From a Specialized Diabetes Center
    Thewjitcharoen, Yotsapon
    Yenseung, Nalin
    Malidaeng, Areeya
    Butadej, Siriwan
    Chotwanvirat, Phawinpon
    Krittiyawong, Sirinate
    Thammawiwat, Chattip
    Himathongkam, Thep
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2021, 129 (09) : 666 - 673
  • [10] Switching to insulin degludec (IDeg) improves glycaemic control in patients with Type 2 diabetes in a real-world setting
    Feher, M.
    Tentolouris, N.
    Knudsen, S.
    Lapolla, A.
    Prager, R.
    Phan, T. M.
    Wolden, M. L.
    Schultes, B.
    DIABETIC MEDICINE, 2018, 35 : 203 - 203
12345